Cover: Development of a New Instrument for Rheumatoid Arthritis

Development of a New Instrument for Rheumatoid Arthritis

The Cedar-Sinai Health-Related Quality of Life Instrument CSHRQ-RA

Published in: Arthritis Care and Research, v. 49, no. 1, Feb. 7, 2003, p. 78-84

Posted on 2003

by Michael Weisman, H. E. Paulus, Simcha M. Russak, Deborah P. Lubeck, Chiun-Fang Chiou, Nishan Sengupta, Joshua J. Ofman, Jeff Borenstein, Alyson B. Moadel, Cathy D. Sherbourne

OBJECTIVE: To update and complement existing instruments, the authors developed a multidimensional disease-specific instrument, intended to reflect the impact of rheumatoid arthritis (RA) with modern treatment options on patient's Health-Related Quality of Life (HRQOL). METHODS: Items were developed from a systematic review of published HRQOL measures and transcripts of RA patient focus groups. Items were refined by an expert panel and administered to 350 patients for psychometric testing. RESULTS: The systematic review identified 228 potential items, and the focus group transcripts identified 96 additional items. Expert review and pilot testing resulted in an initial 58-item instrument. Twenty-six items were excluded due to floor/ceiling effects, poor response rates, or high item-item correlations. Factor analysis identified a 5-factor structure (eigenvalues 1). Multi-trait scaling performed on both completed surveys confirmed the 5 sub-scale structure (Cronbach's > 0.87). CONCLUSION: The CSHQ-RA consists of 33 items that address 5 HRQOL domains, each with high internal consistency. Additional testing will assess the instrument's validity and responsiveness.

This report is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.